High-dose chemotherapy in germ-cell cancer salvage regimens: where next?


DESIGN AND INTERVENTION Between February 1994 and September 2001, this prospective, randomized, phase 3 study recruited patients with relapsing germ-cell tumors from 43 institutions in 11 countries. Eligible patients were aged ≥16 years, had a performance status of 0–2, and had initially responded to first-line platinum-containing chemotherapy. Patients who… (More)
DOI: 10.1038/ncpuro0358


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.